Table 1 Comparison of HER-2 immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH) analysis of 133 breast cancer bone metastases tissue microarrays
HER-2 IHCNoHER-2 FISH
Equivocal(ratio 1.8–2.2)Positive(ratio >2.2)
0671 (1.5%)0
1+381 (2.6%)0
2+1502 (13.7%)
3+13010 (76.9%)